[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 …

…, F Castelli, FS Serino, M Tsilika, P Bakakos… - Nature medicine, 2021 - nature.com
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

…, E Kostis, M Samarkos, P Bakakos… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece

E Apostolopoulou, P Bakakos, T Katostaras… - Respiratory …, 2003 - rc.rcjournal.com
INTRODUCTION: Ventilator-associated pneumonia (VAP) is the most common nosocomial
infection among intensive care unit (ICU) patients. OBJECTIVE: Prospectively identify the …

Is diet partly responsible for differences in COVID‐19 death rates between and within countries?

…, I Baiardini, N Bajrović, P Bakakos… - Clinical and …, 2020 - Wiley Online Library
Reported COVID‐19 deaths in Germany are relatively low as compared to many European
countries. Among the several explanations proposed, an early and large testing of the …

C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia

…, P Plantza, A Rasidakis, P Bakakos - European …, 2010 - Eur Respiratory Soc
We evaluated the performance of procalcitonin (PCT) and C-reactive protein (CRP) threshold
values and kinetics as predictors of ventilator-associated pneumonia (VAP) survival and …

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

…, D Bagnasco, I Baiardini, N Bajrović, P Bakakos… - Allergy, 2021 - Wiley Online Library
Large differences in COVID‐19 death rates exist between countries and between regions of
the same country. Some very low death rate countries such as Eastern Asia, Central Europe, …

[HTML][HTML] Severe eosinophilic asthma

A Bakakos, S Loukides, P Bakakos - Journal of clinical medicine, 2019 - mdpi.com
Asthma is a heterogeneous disease with varying severity. Severe asthma is a subject of
constant research because it greatly affects patients’ quality of life, and patients with severe …

Nrf2‐interacting nutrients and COVID‐19: time for research to develop adaptation strategies

…, I Baiardini, N Bajrović, P Bakakos… - Clinical and …, 2020 - Wiley Online Library
There are large between‐ and within‐country variations in COVID‐19 death rates. Some very
low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have …

[HTML][HTML] New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis

…, K Golebski, Z Strizova, S Loukides, P Bakakos… - Clinical …, 2023 - portlandpress.com
Asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) or without (CRSsNP) are
chronic respiratory diseases. These two disorders often co-exist based on common anatomical, …

[HTML][HTML] Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients

…, M Toumbis, K Tsikritsaki, K Malagari, P Bakakos - Respiratory …, 2016 - Elsevier
Background and objectives Non-Cystic Fibrosis (CF) bronchiectasis is common in Greece
but little attention has been paid to the investigation of its aetiology, clinical, radiological, …